Tilray Brands, Inc. (TLRY)
7.99
+0.16
(+2.04%)
USD |
NASDAQ |
Feb 26, 16:00
7.91
-0.08
(-1.00%)
Pre-Market: 08:53
Tilray Brands Cash from Investing (Quarterly) : -57.73M for Nov. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0051M |
| Aurinia Pharmaceuticals, Inc. | -14.02M |
| Edesa Biotech, Inc. | 0.00 |
| Lexaria Bioscience Corp. | -0.0051M |
| Xenon Pharmaceuticals, Inc. | 38.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.457M |
| Cash from Financing (Quarterly) | 47.55M |
| Free Cash Flow | -67.35M |
| Free Cash Flow Per Share (Quarterly) | -0.1631 |
| Free Cash Flow to Equity (Quarterly) | -13.88M |
| Free Cash Flow to Firm (Quarterly) | -12.15M |
| Free Cash Flow Yield | -8.33% |